ANDA 40872, held by Lannett Co Inc. Phentermine Resin Complex.
As of Nov 16, 2026, ANDA 40872 (Phentermine Resin Complex), held by Lannett Co Inc, was first approved by FDA on Jul 28, 2011, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 28, 2011 | Original application | Approved | None posted |
| Phentermine Resin ComplexEQ 15MG BASE · capsule, extended release;oral | Phentermine Resin Complex | Discontinued |
| Phentermine Resin ComplexEQ 30MG BASE · capsule, extended release;oral | Phentermine Resin Complex | Discontinued |
| May 31, 2017 | Supplement 3Labeling · Standard review | Approved | None posted |
| Dec 6, 2012 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jul 28, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters